Hinge Health, Inc.
HNGE
$40.45
$1.614.15%
NYSE
| 03/31/2025 | |||||
|---|---|---|---|---|---|
| Revenue | 49.71% | ||||
| Total Other Revenue | -- | ||||
| Total Revenue | 49.71% | ||||
| Cost of Revenue | -4.75% | ||||
| Gross Profit | 72.99% | ||||
| SG&A Expenses | 6.70% | ||||
| Depreciation & Amortization | -- | ||||
| Other Operating Expenses | -- | ||||
| Total Operating Expenses | -3.02% | ||||
| Operating Income | 141.81% | ||||
| Income Before Tax | 168.95% | ||||
| Income Tax Expenses | 531.65% | ||||
| Earnings from Continuing Operations | 164.76% | ||||
| Earnings from Discontinued Operations | -- | ||||
| Extraordinary Item & Accounting Change | -- | ||||
| Minority Interest in Earnings | -- | ||||
| Net Income | 164.76% | ||||
| EBIT | 141.81% | ||||
| EBITDA | 144.27% | ||||
| EPS Basic | 500.14% | ||||
| Normalized Basic EPS | 160.18% | ||||
| EPS Diluted | 166.16% | ||||
| Normalized Diluted EPS | 109.95% | ||||
| Average Basic Shares Outstanding | 14.56% | ||||
| Average Diluted Shares Outstanding | 593.01% | ||||
| Dividend Per Share | -- | ||||
| Payout Ratio | -- | ||||